An Expert's Perspective on Advancing Treatment Progress for Blood Cancers
Dr. Steven Rosen, from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University in Chicago, expresses his excitement about advancements in blood cancer treatments presented at the 2012 American Society of Hematology annual meeting. Dr. Rosen explains one of the key factors for determining the best treatment course is understanding the genetics of each individual's cancer. As survivorship increases, the paradigm of care is shifting to focus on long term disease management and maintaining quality of life.
Experts & Guests
Steven T. Rosen, M.D.
Director, Robert H. Lurie Comprehensive Cancer Center, Northwestern Memorial HospitalDr. Steven Rosen is the Genevieve Teuton Professor of Medicine and Director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. He received his medical degree from the Northwestern University Feinberg School of Medicine and completed his residency training at McGaw Medical Center of Northwestern University. Dr. Rosen is board certified in hematology, internal medicine and medical oncology. more >